Given the limited treatment options for central nervous system diseases like HIE, the therapeutic strategy proposed here to activate RORα provides a promising approach for controlling neuroinflammation and potentially improving long-term outcomes in HIE patients. This evidence concerns the gene RORA and central nervous system disorder.